Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
University of Palermo
Maastricht University Medical Center
Ohio State University Comprehensive Cancer Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Massachusetts General Hospital
University Hospital Bispebjerg and Frederiksberg
University of Miami
Maastricht University Medical Center
University of California, Irvine
Technische Universität Dresden
Massachusetts General Hospital
Duke University
Maastricht University Medical Center
Diagnostic Photonics, Inc.
Diagnostic Photonics, Inc.
Centre Hospitalier Universitaire de Saint Etienne
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Case Comprehensive Cancer Center
Diagnostic Photonics, Inc.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
University of Oklahoma
M.D. Anderson Cancer Center
City of Hope Medical Center
Zealand University Hospital